PAZEO

This brand name is authorized in Canada, Ecuador, Singapore, United States

Active ingredients

The drug PAZEO contains one active pharmaceutical ingredient (API):

1 Olopatadine UNII 2XG66W44KF - OLOPATADINE HYDROCHLORIDE

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action. Read about Olopatadine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PAZEO Ophthalmic solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GX09	Olopatadine	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02458551
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1883-MEE-0316
Country: SG	Health Sciences Authority	Identifier(s): 15242P
Country: US	FDA, National Drug Code	Identifier(s): 0065-4273